{"disease":{"id":"anticoagulant","name":"anticoagulant"},"drugs":{"marketed":[{"drug_id":"vitamin-k1","indication_name":"Anticoagulant-induced prothrombin deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin K1","generic_name":"Phytonadione","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Vitamin K-dependent carboxylase; vitamin K epoxide reductase complex (indirect antagonism of warfarin effects)","drug_class":"Vitamin K [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"phytonadione","indication_name":"Anticoagulant-induced prothrombin deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHYTONADIONE","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1 (VKORC1)","drug_class":"Vitamin K [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"andexanet-alfa","indication_name":"Direct acting anticoagulant adverse reaction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anxa","generic_name":"ANDEXANET ALFA","company_name":"Portola Pharamceuticals US","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":48,"revenue":null,"mechanism":"Anxa works by binding to and neutralizing factor Xa inhibitors, reversing anticoagulation."},{"drug_id":"vitamin-k1","indication_name":"Anticoagulant-induced prothrombin deficiency caused by coumarin derivatives","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin K1","generic_name":"Phytonadione","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Vitamin K-dependent carboxylase; vitamin K epoxide reductase complex (indirect antagonism of warfarin effects)","drug_class":"Vitamin K [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"vitamin-k1","indication_name":"Anticoagulant-induced prothrombin deficiency caused by indanedione derivatives","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin K1","generic_name":"Phytonadione","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Vitamin K-dependent carboxylase; vitamin K epoxide reductase complex (indirect antagonism of warfarin effects)","drug_class":"Vitamin K [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"phytomenadione","indication_name":"Anticoagulant-Induced Prothrombin Deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"phytomenadione","company_name":"Instituto Mexicano del Seguro Social","drug_phase":"phase_2","molecular_target":"Alpha-synuclein","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"phytonadione","indication_name":"Anticoagulant-induced prothrombin deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHYTONADIONE","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1 (VKORC1)","drug_class":"Vitamin K [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"andexanet","indication_name":"Direct acting anticoagulant adverse reaction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Andexanet","company_name":"Portola Pharmaceuticals","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"phylloquinone","indication_name":"Anticoagulant-Induced Prothrombin Deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Phylloquinone","company_name":"Guy's and St Thomas' NHS Foundation Trust","drug_phase":"phase_2","molecular_target":"Alpha-synuclein","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01653405","title":"Improving Anticoagulation Control in VISN 1","phase":"NA","overall_status":"COMPLETED","enrollment_count":1260576,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT04878497","title":"Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty","phase":"","overall_status":"UNKNOWN","enrollment_count":1000000,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04681482","title":"Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare","phase":"","overall_status":"COMPLETED","enrollment_count":107383,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06020560","title":"Study of Low Molecular Weight Heparins","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":65000,"lead_sponsor_name":"Herlev Hospital","has_results":false},{"nct_id":"NCT03367325","title":"Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":63001,"lead_sponsor_name":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","has_results":false},{"nct_id":"NCT05645913","title":"Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation","phase":"","overall_status":"UNKNOWN","enrollment_count":56272,"lead_sponsor_name":"Ajou University School of Medicine","has_results":false},{"nct_id":"NCT03292666","title":"Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study","phase":"","overall_status":"COMPLETED","enrollment_count":39603,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03209258","title":"The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":7067,"lead_sponsor_name":"The George Institute for Global Health, China","has_results":false},{"nct_id":"NCT05852197","title":"Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT05548777","title":"Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed","phase":"","overall_status":"COMPLETED","enrollment_count":5480,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04044924","title":"Geriatric Head Trauma Short Term Outcomes Project","phase":"","overall_status":"COMPLETED","enrollment_count":5387,"lead_sponsor_name":"Florida Atlantic University","has_results":false},{"nct_id":"NCT07383155","title":"Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":5270,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT03760874","title":"Atrial Fibrillation Research Database","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT05378308","title":"NOACs Use in AF or VTE (SUNSHINE Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Henan Provincial People's Hospital","has_results":false},{"nct_id":"NCT06341231","title":"Personalized Anticoagulant Therapy for Pulmonary Thromboembolism","phase":"","overall_status":"RECRUITING","enrollment_count":4700,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT06108414","title":"Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":4374,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT04774341","title":"Personalized Evidence-based Medicine in Patients With Atrial Fibrillation","phase":"","overall_status":"COMPLETED","enrollment_count":4200,"lead_sponsor_name":"Center of Personalized Medicine, Pirogova","has_results":false},{"nct_id":"NCT03527615","title":"Clinical Pharmacist Anticoagulant Stewardship","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Hadassah Medical Organization","has_results":false},{"nct_id":"NCT06401863","title":"Shared Decision for Drug Interactions in Oral Anticoagulation","phase":"NA","overall_status":"RECRUITING","enrollment_count":3691,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT05332158","title":"Medicines Gaps Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"The Leeds Teaching Hospitals NHS Trust","has_results":false},{"nct_id":"NCT03828162","title":"Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly","phase":"","overall_status":"COMPLETED","enrollment_count":2943,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03244020","title":"LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2868,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05801068","title":"Perioperative Management of Factor Xa Inhibitors","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03871283","title":"Anticoagulation and Antiplatelet Management During Perioperative Period","phase":"","overall_status":"COMPLETED","enrollment_count":2400,"lead_sponsor_name":"Erasme University Hospital","has_results":false},{"nct_id":"NCT04329390","title":"MAC Project, Monitoring of AntiCoagulant Therapies (MAC)","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Quovadis Associazione","has_results":false},{"nct_id":"NCT03803579","title":"Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Arianna Anticoagulazione Foundation","has_results":false},{"nct_id":"NCT04684056","title":"Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation","phase":"","overall_status":"UNKNOWN","enrollment_count":1864,"lead_sponsor_name":"Wuhan Asia Heart Hospital","has_results":false},{"nct_id":"NCT03669068","title":"Gastrointestinal Endoscopy in Patients With Prothrombotic Conditions: THE ENDOHEM REGISTRY","phase":"","overall_status":"COMPLETED","enrollment_count":1602,"lead_sponsor_name":"Hospital Universitario Ramon y Cajal","has_results":false},{"nct_id":"NCT04168398","title":"Clopidogrel Aspirin Therapy (CAT) Versus Apixiban Aspirin Therapy (AAT) After Lower Limb Revascularization","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1536,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT02360943","title":"Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT04291287","title":"Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT05710562","title":"Epidemiological Description of Health Determinants in Italian Anticoagulated Population","phase":"","overall_status":"UNKNOWN","enrollment_count":1495,"lead_sponsor_name":"IRCCS Policlinico S. Donato","has_results":false},{"nct_id":"NCT06947707","title":"Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients","phase":"","overall_status":"RECRUITING","enrollment_count":1486,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT04257487","title":"Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1455,"lead_sponsor_name":"Arianna Anticoagulazione Foundation","has_results":false},{"nct_id":"NCT04977076","title":"Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1214,"lead_sponsor_name":"Zuyderland Medisch Centrum","has_results":false},{"nct_id":"NCT02898090","title":"Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions","phase":"","overall_status":"COMPLETED","enrollment_count":1213,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06168838","title":"Anticoagulant-associated Intracranial Hemorrhage","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez","has_results":false},{"nct_id":"NCT04010955","title":"Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT05705076","title":"Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1100,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT04719182","title":"Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":1011,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT05319340","title":"I.M. Sechenov First Moscow State Medical University (Sechenov University)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT07242326","title":"SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"Kotyora Family Medicine Health Management and Education Association","has_results":false},{"nct_id":"NCT03558295","title":"CHAOS Registry Study","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"A.O.U. Città della Salute e della Scienza","has_results":false},{"nct_id":"NCT06627933","title":"Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT06187311","title":"Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":940,"lead_sponsor_name":"Korea University Anam Hospital","has_results":false},{"nct_id":"NCT03182829","title":"In Vitro Diagnostic Test for DOAC in Urine","phase":"","overall_status":"COMPLETED","enrollment_count":880,"lead_sponsor_name":"Doasense GmbH","has_results":true},{"nct_id":"NCT04623177","title":"Thromboprophylaxis for Patients in ICU With COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":822,"lead_sponsor_name":"Instituto de Investigacion Sanitaria La Fe","has_results":false},{"nct_id":"NCT05224388","title":"Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.","phase":"","overall_status":"COMPLETED","enrollment_count":813,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT03678506","title":"Apixaban for Extended Anticoagulation (APIDULCIS)","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":800,"lead_sponsor_name":"Arianna Anticoagulazione Foundation","has_results":false},{"nct_id":"NCT03264937","title":"Social-software iMproving wARfarin Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":735,"lead_sponsor_name":"Wuhan Asia Heart Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}